{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-160755","form_type":"8-K","ticker":"VNDA","cik":"0001347178","company_name":"Vanda Pharmaceuticals Inc.","filed_at":"2024-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.038962+00:00","generated_at":"2026-06-01T04:34:09.681945+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Vanda confirms revised unsolicited takeover proposal from Future Pak at $8.50-$9.00 per share plus CVRs","bullets":["Future Pak LLC proposes $8.50-$9.00 per share cash plus Contingent Value Rights for Vanda Pharmaceuticals.","Vanda Board will review the revised non-binding proposal with financial and legal advisors.","No shareholder action required at this time; company will not comment further until Board completes review."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-160755","json":"https://secwatch.observer/filing/0001193125-24-160755.json","markdown":"https://secwatch.observer/filing/0001193125-24-160755.md","text":"https://secwatch.observer/filing/0001193125-24-160755.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347178/000119312524160755/0001193125-24-160755-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347178/000119312524160755/d843445d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:34:09.681945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}